Xmr inhibitors are a class of chemical compounds known for their ability to modulate specific biochemical processes, often by targeting key molecular pathways involved in the regulation of cellular functions. These inhibitors are typically small molecules that interact with proteins or enzymes, altering their activity by either blocking active sites or influencing conformational changes that affect their function. Xmr inhibitors are highly specific, often designed to interact with precise molecular targets, making them valuable tools in understanding intricate biochemical pathways and processes. The inhibition of these pathways can lead to significant changes in cellular behavior, which provides researchers valuable insights into the underlying molecular mechanisms governing cellular homeostasis and other important biological processes.
Xmr inhibitors may vary widely in structure depending on their intended target within the biochemical pathway, and they often exhibit diverse physicochemical properties, such as solubility, stability, and binding affinity, that influence their effectiveness as research tools. Structural modifications of these inhibitors are frequently undertaken to optimize their interaction with the target proteins, enhancing their ability to modulate the desired biochemical pathways with minimal off-target effects. This selectivity makes Xmr inhibitors crucial for exploring the functions of complex molecular networks, as they allow for precise control and observation of specific interactions within a controlled environment. Their versatility and precision in inhibiting molecular functions make them essential components in experimental systems designed to elucidate molecular mechanisms and pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D inhibits gene expression by preventing RNA polymerase activity, which is crucial for the transcription process of the predicted gene 5169. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Triptolide inhibits RNA polymerase activity, which could result in decreased transcription and potentially impact the expression of the predicted gene 5169. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $95.00 $322.00 $663.00 $1438.00 | 6 | |
Rifampicin inhibits bacterial RNA polymerase, potentially impacting RNA polymerase activity involved in the transcription of the predicted gene 5169. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
This compound specifically inhibits RNA polymerase II, which is crucial for mRNA transcription and could potentially affect the expression of the predicted gene 5169. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $68.00 $261.00 | 8 | |
Mycophenolic acid inhibits inosine monophosphate dehydrogenase, disrupting guanine nucleotide synthesis, potentially impacting gene expression, including the predicted gene 5169. | ||||||
Ellipticine | 519-23-3 | sc-200878 sc-200878A | 10 mg 50 mg | $142.00 $558.00 | 4 | |
Ellipticine intercalates into DNA, leading to the inhibition of RNA and DNA synthesis, potentially impacting the expression of the predicted gene 5169. | ||||||
Triamterene | 396-01-0 | sc-213103A sc-213103 | 1 g 5 g | $22.00 $53.00 | ||
Triamterene has been shown to inhibit RNA synthesis, potentially affecting the expression of the predicted gene 5169. | ||||||
Aclacinomycin A | 57576-44-0 | sc-200160 | 5 mg | $129.00 | 10 | |
Aclarubicin intercalates into DNA and inhibits topoisomerase II, potentially impacting DNA replication and transcription of the predicted gene 5169. | ||||||